Long-term safety and effectiveness of first line dual anti-hypertensives therapy: a nationwide multi-database study from South Korea and Taiwan

The study aims to evaluate the real-world safety of the novel ARB-azilsartan in both Taiwanese and South Korean populations.

Share the Project